TCL Archive Advice Rolls In As Upton Proceeds With NCI Reorganization, Stands Firm On His Program March 17, 1978
TCL Archive Von Eschenbach takes leave of absence from NCI, resigns from C-Change board. Acting FDA commissioner’s drug approval strategy rooted in unproven science. Von Eschenbach told NCI deputies he might drop in on meetings. Who’s really in charge? October 7, 2005
